$12.2 B

DGX Mkt cap, 04-Dec-2018

$1.9 B

Quest Diagnostics Revenue Q3, 2018
Quest Diagnostics Gross profit (Q3, 2018)667 M
Quest Diagnostics Gross profit margin (Q3, 2018), %35.3%
Quest Diagnostics Net income (Q3, 2018)227 M
Quest Diagnostics EBIT (Q3, 2018)304 M
Quest Diagnostics Cash, 30-Sep-2018263 M
Quest Diagnostics EV15.6 B

Quest Diagnostics Revenue

Quest Diagnostics revenue was $7.71 b in FY, 2017 which is a 2.6% year over year increase from the previous period.

Embed Graph

Quest Diagnostics Revenue Breakdown

Embed Graph

Quest Diagnostics revenue breakdown by business segment: 95.6% from Diagnostic Information Services and 4.4% from Other

Quest Diagnostics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

7.1b7.4b7.5b7.5b7.7b

Revenue growth, %

4%1%0%3%

Cost of goods sold

4.3b4.6b4.7b4.6b4.7b

Gross profit

2.8b2.8b2.8b2.9b3.0b

Gross profit Margin, %

39%38%38%39%39%

General and administrative expense

1.7b1.7b1.8b

Operating expense total

1.4b1.6b1.8b

Depreciation and amortization

81.0m72.0m74.0m

EBIT

1.5b983.0m1.4b1.3b1.2b

EBIT margin, %

21%13%19%17%15%

Interest expense

159.0m164.0m153.0m143.0m151.0m

Pre tax profit

1.1b1.1b1.0b

Income tax expense

500.0m262.0m373.0m429.0m241.0m

Net Income

883.0m592.0m753.0m696.0m824.0m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

1.8b1.7b1.9b1.9b1.8b1.9b1.9b1.9b1.9b1.9b1.9b1.9b1.9b1.9b3.8b1.9b

Cost of goods sold

1.1b1.1b1.2b1.2b1.2b1.2b1.2b1.1b1.2b1.2b1.2b1.2b1.2b1.2b2.5b1.2b

Gross profit

698.6m645.0m728.0m726.0m676.0m743.0m718.0m719.0m751.0m728.0m734.0m773.0m741.0m658.0m1.3b667.0m

Gross profit Margin, %

39%37%38%38%37%39%38%39%39%39%39%40%38%35%35%35%

General and administrative expense

423.0m415.0m440.0m446.0m419.0m429.0m402.0m442.0m430.0m409.0m437.0m437.0m423.0m363.0m714.0m354.0m

Operating expense total

1.1b1.5b1.6b1.6b1.6b1.6b1.2b442.0m430.0m409.0m437.0m437.0m423.0m363.0m714.0m354.0m

Depreciation and amortization

22.0m44.0m22.0m

EBIT

689.5m208.0m262.0m256.0m228.0m301.0m631.0m257.0m422.0m322.0m279.0m319.0m298.0m272.0m577.0m304.0m

EBIT margin, %

39%12%14%13%12%16%34%14%22%17%15%16%15%14%15%16%

Interest expense

40.0m39.0m42.0m41.0m45.0m37.0m35.0m36.0m34.0m37.0m36.0m38.0m38.0m41.0m83.0m41.0m

Pre tax profit

112.0m207.0m

Income tax expense

245.9m65.0m87.0m82.0m42.0m78.0m(239.0m)(68.0m)(183.0m)(95.0m)(78.0m)(94.0m)(92.0m)(52.0m)(94.0m)(48.0m)

Net Income

413.9m111.0m142.0m139.0m70.0m129.0m354.0m114.0m209.0m205.0m175.0m207.0m175.0m189.0m422.0m227.0m

Quest Diagnostics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

187.0m192.0m133.0m359.0m137.0m

Accounts Receivable

926.0m924.0m

Prepaid Expenses

155.0m150.0m

Inventories

91.0m110.0m84.0m82.0m95.0m

Current Assets

1.4b1.6b1.5b1.5b1.3b

PP&E

805.0m933.0m925.0m1.0b1.1b

Goodwill

5.6b6.0b5.9b6.0b6.3b

Total Assets

8.9b9.9b10.0b10.1b10.5b

Accounts Payable

920.0m1.2b1.0b975.0m1.0b

Short-term debt

212.0m518.0m159.0m6.0m36.0m

Current Liabilities

1.1b1.7b1.2b981.0m1.1b

Long-term debt

3.1b3.2b3.5b3.7b3.7b

Total Debt

3.3b3.8b3.7b3.7b3.8b

Common Stock

2.0m2.0m

Additional Paid-in Capital

2.4b2.4b2.5b2.5b2.6b

Retained Earnings

5.4b5.7b6.2b6.6b7.1b

Total Equity

4.0b4.3b4.7b4.7b5.0b

Debt to Equity Ratio

0.8 x0.9 x0.8 x0.8 x0.8 x

Debt to Assets Ratio

0.4 x0.4 x0.4 x0.4 x0.4 x

Financial Leverage

2.3 x2.3 x2.1 x2.2 x2.1 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

158.3m144.0m144.0m170.0m974.0m150.0m123.0m128.0m283.0m406.0m367.0m314.0m350.0m124.0m132.0m263.0m

Inventories

85.2m99.0m109.0m111.0m106.0m109.0m86.0m82.0m80.0m82.0m77.0m83.0m100.0m94.0m91.0m95.0m

Current Assets

1.4b1.5b1.5b1.6b2.4b1.5b1.6b1.5b1.5b1.6b1.6b1.5b1.5b1.4b1.4b1.6b

PP&E

749.4m851.0m884.0m888.0m902.0m906.0m886.0m925.0m937.0m952.0m1.0b1.0b1.1b1.2b1.2b1.2b

Goodwill

5.6b5.9b6.0b6.0b6.0b6.0b5.9b6.0b6.0b6.0b6.0b6.1b6.2b6.4b6.4b6.4b

Total Assets

8.9b9.6b9.8b9.8b10.6b9.7b10.1b10.1b10.1b10.2b10.1b10.2b10.4b10.7b10.7b11.0b

Accounts Payable

994.3m969.0m1.0b1.1b1.0b1.1b973.0m932.0m1.1b1.0b979.0m912.0m1.0b976.0m957.0m1.1b

Short-term debt

244.7m223.0m220.0m132.0m1.0b168.0m160.0m158.0m7.0m7.0m6.0m5.0m5.0m141.0m305.0m304.0m

Current Liabilities

1.2b1.2b1.3b1.2b2.1b1.2b1.1b1.1b1.1b1.0b985.0m917.0m1.1b1.1b1.3b1.4b

Long-term debt

3.1b3.7b3.7b3.7b3.7b3.6b3.6b3.7b3.8b3.8b3.7b3.7b3.8b3.7b3.4b3.4b

Total Debt

3.4b3.9b4.0b3.9b4.7b3.7b3.7b3.9b3.8b3.8b3.7b3.7b3.8b3.9b3.7b3.7b

Additional Paid-in Capital

2.3b2.4b2.4b2.4b2.4b2.4b2.5b2.5b2.5b2.5b2.5b2.6b2.6b2.6b2.6b2.7b

Retained Earnings

5.3b5.4b5.5b5.6b5.7b5.8b6.1b6.2b6.4b6.5b6.7b6.8b6.9b7.2b7.4b7.5b

Total Equity

3.9b4.0b4.1b4.2b4.3b4.3b4.6b4.7b4.6b4.7b4.7b4.7b4.8b5.1b5.3b5.4b

Debt to Equity Ratio

0.9 x1 x1 x0.9 x1.1 x0.9 x0.8 x0.8 x0.8 x0.8 x0.8 x0.8 x0.8 x0.8 x0.7 x0.7 x

Debt to Assets Ratio

0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.4 x0.3 x0.3 x

Financial Leverage

2.3 x2.4 x2.4 x2.3 x2.5 x2.2 x2.2 x2.2 x2.2 x2.2 x2.2 x2.1 x2.2 x2.1 x2 x2 x

Quest Diagnostics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

883.0m592.0m753.0m696.0m824.0m

Depreciation and Amortization

304.0m249.0m270.0m

Accounts Receivable

(247.0m)(312.0m)(262.0m)(343.0m)(298.0m)

Accounts Payable

(21.0m)68.0m(24.0m)56.0m(8.0m)

Cash From Operating Activities

652.0m938.0m821.0m1.1b1.2b

Cash From Investing Activities

328.0m(1.0b)(362.0m)(152.0m)(805.0m)

Long-term Borrowings

(900.0m)(1.6b)(2.5b)(1.7b)(182.0m)

Dividends Paid

(185.0m)(187.0m)(212.0m)(223.0m)(247.0m)

Cash From Financing Activities

(1.1b)92.0m(518.0m)(691.0m)(592.0m)

Net Change in Cash

(59.0m)226.0m(222.0m)

Free Cash Flow

421.0m630.0m558.0m776.0m923.0m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

732.1m111.0m253.0m392.0m70.0m199.0m553.0m114.0m324.0m529.0m175.0m382.0m557.0m189.0m422.0m649.0m

Depreciation and Amortization

211.0m75.0m156.0m235.0m78.0m153.0m230.0m62.0m123.0m186.0m62.0m128.0m197.0m74.0m151.0m228.0m

Accounts Receivable

(252.4m)(152.0m)(191.0m)(260.0m)(97.0m)(163.0m)(214.0m)(145.0m)(249.0m)(316.0m)(117.0m)(185.0m)(265.0m)(97.0m)(127.0m)(166.0m)

Accounts Payable

(76.8m)(86.0m)(39.0m)20.0m(120.0m)(49.0m)(41.0m)(77.0m)23.0m43.0m(95.0m)(93.0m)(3.0m)(68.0m)(64.0m)51.0m

Cash From Operating Activities

441.6m84.0m364.0m635.0m52.0m327.0m539.0m143.0m464.0m765.0m196.0m490.0m852.0m180.0m503.0m905.0m

Cash From Investing Activities

433.6m(636.0m)(841.0m)(934.0m)(55.0m)(123.0m)(237.0m)(190.0m)27.0m(45.0m)(22.0m)(192.0m)(439.0m)(204.0m)(330.0m)(455.0m)

Long-term Borrowings

(757.2m)(923.0m)(1.2b)(1.5b)(440.0m)(1.8b)(2.2b)(453.0m)(1.7b)(1.7b)(2.0m)(3.0m)(5.0m)(832.0m)(1.6b)(1.7b)

Dividends Paid

(141.0m)(43.0m)(91.0m)(139.0m)(48.0m)(103.0m)(158.0m)(55.0m)(111.0m)(168.0m)(62.0m)(124.0m)(186.0m)(61.0m)(129.0m)(198.0m)

Cash From Financing Activities

(1.0b)509.0m434.0m282.0m785.0m(246.0m)(371.0m)42.0m(341.0m)(447.0m)(166.0m)(343.0m)(422.0m)11.0m(178.0m)(324.0m)

Free Cash Flow

286.2m16.0m247.0m416.0m(4.0m)210.0m370.0m96.0m360.0m600.0m154.0m383.0m682.0m107.0m352.0m673.0m

Quest Diagnostics Ratios

USDY, 2018

EV/EBIT

51.5 x

EV/CFO

17.3 x

EV/FCF

23.2 x

Debt/Equity

0.7 x

Debt/Assets

0.3 x

Financial Leverage

2 x
Report incorrect company information

Quest Diagnostics Operating Metrics

FY, 2016

Accounts

250 k

Patents Issued

700

Patents Pending

570

Patient Service Centers

2.20 k
Report incorrect company information

Quest Diagnostics Employee Rating

3.41992 votes
Culture & Values
3.3
Work/Life Balance
3.2
Senior Management
3.0
Salary & Benefits
3.4
Career Opportunities
3.2
Source